Supplements

NIV may confer greater short-term clinical benefit in children with severe acute asthma requiring respiratory support

In a systematic review and meta-analysis of pediatric asthma exacerbations, non-invasive ventilation (NIV) showed the greatest improvement in asthma scores compared to oxygen (MD = 1.24, p = 0.07), reaching significance in sensitivity analysis (MD = 2.5, p < 0.001). High-flow nasal cannula (HFNC) showed no significant benefit over oxygen (MD = 0.24, p = 0.58) and was associated with higher failure rates compared to NIV (12.6% vs. 2.6%, OR = 5.3, p < 0.001).

Last updated: Aug 28, 2026•0 RCTs•1 Meta-analyses•📖 Read as article →

Evidence Score

Evidence Score63/100
Human RCT☆☆☆☆☆
Meta-analysis★★★☆☆
Mechanism★★★★★
Safety★★★★☆
Confidencelow

Study Evidence

Study 1. Comparing Respiratory Support Modalities in Pediatric Asthma Exacerbation-A Systematic Review and Meta-Analysis.

meta

Odeh MA, Kiswani G, Gileles-Hillel A · Pediatric reports (2026)

Participants: 233
Duration: Not specified
Intervention: Comparison of respiratory support modalities: NIV, HFNC, and IMV versus standard oxygen
Outcome: Change in asthma score, PICU length of stay, treatment failure rate, intubation odds
Effect Size: MD = 1.24 (NIV vs oxygen, p = 0.07); MD = 2.5 (sensitivity analysis, p < 0.001); OR = 5.3 (HFNC failure vs NIV)
Population: Children (0-18 years) hospitalized for acute asthma exacerbation requiring respiratory support

Result: In a systematic review and meta-analysis of pediatric asthma exacerbations, non-invasive ventilation (NIV) showed the greatest improvement in asthma scores compared to oxygen (MD = 1.24, p = 0.07), reaching significance in sensitivity analysis (MD = 2.5, p < 0.001). High-flow nasal cannula (HFNC) showed no significant benefit over oxygen (MD = 0.24, p = 0.58) and was associated with higher failure rates compared to NIV (12.6% vs. 2.6%, OR = 5.3, p < 0.001).

PubMed: 42646649DOI: 10.3390/pediatric18040104

Mechanism Graph

NIV provides positive pressure support, reducing work of breathing and improving alveolar ventilation
↓
Improved ventilation and oxygenation lead to faster resolution of bronchospasm and inflammation
↓
This results in greater improvement in asthma severity scores compared to oxygen alone
↓
Result: NIV may be more effective than HFNC or oxygen in short-term clinical improvement

Limitations

  • ⚠Limited number of RCTs (n=5) and heterogeneous data
  • ⚠Observational studies may have confounding factors and bias
  • ⚠Racial disparities were analyzed narratively, not quantitatively
  • ⚠No standardized outcomes across studies

Frequently Asked Questions

Is NIV better than high-flow nasal cannula for pediatric asthma exacerbation?▼

The meta-analysis suggests NIV may provide greater short-term improvement in asthma scores and has a lower failure rate compared to HFNC (2.6% vs 12.6%). However, evidence is limited and heterogeneous.

Does high-flow nasal cannula reduce PICU stay in children with asthma?▼

No, the observational network meta-analysis found no difference in PICU stay between respiratory support modalities, but a subgroup analysis showed HFNC was associated with a 2-fold increase in PICU stay compared to standard oxygen (p = 0.04).

Are there racial disparities in respiratory support for pediatric asthma?▼

Yes, the study found that Black children had higher odds of intubation, indicating racial disparities in outcomes.

What is the recommended respiratory support for severe pediatric asthma?▼

Based on this review, NIV may be preferred over HFNC or oxygen alone for short-term clinical benefit, but more high-quality studies are needed to confirm.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Odeh MA, Kiswani G, Gileles-Hillel A. "Comparing Respiratory Support Modalities in Pediatric Asthma Exacerbation-A Systematic Review and Meta-Analysis.." Pediatric reports, 2026. PMID: 42646649 DOI: 10.3390/pediatric18040104
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.